Ceft Biopharma

ZEVALIN

View Prices
  1. Home
    2.  / 
  2. A Code
    3.  / ZEVALIN – A9543

Manufacturer:

Ceft Biopharma

Name:

ZEVALIN

HCPCS Code Descriptor:

Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries

Category:

A Code

HCPCS:

A9543

NDC(s):

72893-0007-04

Primary Type:

Radiopharmaceutical

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

ZEVALIN is a Radiopharmaceutical drug manufactured by Ceft Biopharma and administered via the Intravenous route of administration. The A Code: A9543 is aligned to the drug ZEVALIN.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/06

HCPCS Effective Date:

1/1/06

HCPCS Short Description:

Y90 ibritumomab, rx

Billing and Coding Guide:

Not Found

Patient Assistance:

Not Found